MS: Busting the Myths
December 17, 2019 | Advocacy, Education, Funding, Research
“Is it reasonable to wait four months for my neurology referral or MRI?” It’s a surprisingly common question, and that worries us. We regularly receive calls from distressed people experiencing multiple sclerosis (MS) symptoms for the first time or in […]
August 18, 2017
The below disease modifying treatments (DMT’s) are available for the treatment of MS in New Zealand. First line treatments for Relapsing Remitting MS (funded) Ocrevus® (Ocrelizumab) Gilenya® (Fingolimod) Aubagio® (teriflunomide) Tecfidera® (Dimethyl fumarate) Tysabri® (Natalizumab) Second line treatments for […]